Infertility treatment: from cookery to science. The epidemiology of randomised controlled trials

BJOG: An International Journal of Obstetrics & Gynaecology

Volumn 100, Issue 11, 1993, Pages 1005-1036

  Vandekerckhove, P ^a   O'Donovan, P A ^a   Lilford, R J ^a   Harada, T W ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ASCORBIC ACID; BROMOCRIPTINE; BUSERELIN; CHORIONIC GONADOTROPIN; CLOMIFENE; CORTICOSTEROID; CYCLOFENIL; DANAZOL; DEXAMETHASONE; DYDROGESTERONE; FOLLITROPIN; GESTRINONE; GONADORELIN AGONIST; GROWTH HORMONE; HORMONE; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LEVAMISOLE; MEDROXYPROGESTERONE ACETATE; MESTEROLONE; METHYLPREDNISOLONE; NAFARELIN; PROGESTERONE; TAMOXIFEN; UNINDEXED DRUG;

ARTICLE; ARTIFICIAL INSEMINATION; CLINICAL TRIAL; FEMALE; FETUS OUTCOME; HUMAN; INFERTILITY; MALE; PRIORITY JOURNAL;

FEMALE; HUMAN; INFERTILITY; MALE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0027361795     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1993.tb15142.x     Document Type: Article

References (324)

1. Double‐blind cross over treatment with mesterolone and placebo of subfertile oligozoospermic men—value of testicular biopsy
2. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilisation programme
3. Comparative trial of luteinising hormone‐releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotrophin in an assisted conception program
4. Transvaginal ultrasonic needle guided aspiration of pelvic inflammatory cystic masses before ovulation induction for in vitro fertilisation
5. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective randomised clinical trial
6. Bromocriptine therapy in oligozoospermic infertile men
7. Tamoxifen citrate therapy in male infertility
8. Pregnancy rates after hysterosalpingography with oil‐ and water‐soluble contrast media
9. Randomisation and baseline comparison in clinical trials
10. Luteal phase deficiency and infertility: difficulties encountered in diagnosis and treatment
11. Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in vitro fertilisation: a prospective randomised comparison
12. Ovarian follicular maturation in women. I. Intermittent versus daily administration of human menopausal gonadotrophin
13. IVF‐ET in women with refractory polycystic ovarian disease
14. Early pregnancy support in an in vitro fertilisation program: does human chorionic gonadotrophin reduce the miscarriage rate?
15. The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotrophin with and without leuprolide acetate
16. Simplified sperm washing techniques and intrauterine insemination
17. A controlled trial of the use of erythromycin for men with asthenospermia
18. Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency
19. Can premature luteinisation in superovulation protocols be prevented by aspiration of an ill‐timed leading follicle?
20. A prospective randomised controlled trial comparing urinary luteinising hormone dipsticks and basal body temperature charts with time donor insemination
21. Efficacy of danazol treatment for minimal endometriosis in infertile women: a prospective, randomised study
22. Effects of kallikrein on male subfertility/a double blind cross over study
23. The effect of dydrogesterone supplementation in an IVF programme
24. The effect of hCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme
25. An improved use of buserelin in ovarian stimulation for in vitro fertilisation
26. The influence of patient insemination on the implantation rate in an in vitro fertilisation and embryo transfer program
27. An increased initial follicle‐stimulating hormone/luteinising hormone ratio does not affect ovarian responses and the outcomes of in vitro fertilisation
28. Bovine serum albumin (BSA) can replace patient serum as a protein source in an in vitro fertilisation (IVF) program
29. Premenstrual tension and functional infertility: aetiology and treatment
30. A randomised comparative study of purified follicle stimulating hormone and human menopausal gonadotrophin after pituitary desensitisation with Buserelin for superovulation and in vitro fertilisation
31. Comparison of ovarian stimulation regimens for in vitro fertilisation (IVF) with and without a gonadotrophin‐releasing hormone (GnRH) agonist: results of a randomised study
32. Combined human menopausal gonadotrophin therapy and donor insemination
33. Effect of nafarelin versus danazol on lipids and calcium metabolism
34. Gonadotrophin suppression by the synthetic androgen mesterolone in idiopathic oligospermia
35. The effects of mesterolone on sperm counts on idiopathic oligospermia
36. Dosage aspects of danazol therapy in endometriosis: short‐term and long‐term effectiveness
37. Luteal dysfunction in ovulation induction: the role of repetitive human chorionic gonadotropin supplementation during the luteal phase
38. Pretreatment of sperm with human follicular fluid for borderline male infertility
39. A randomised trial of laparoscopy and transvaginal ultrasound‐directed oocyte pickup for in vitro fertilisation
40. Improved cryopreserved semen fecundability in an alternating fresh‐frozen artificial insemination programme
41. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol
42. Antiestrogens as treatment of female and male infertilities
43. A randomised trial of human chorionic gonadotrophin support following in vitro fertilisation and embryo transfer
44. Purified follicle‐stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective
45. Luteal support after luteinising hormone‐releasing hormone agonist for in vitro fertilisation: superiority of human chorionic gonadotrophin over oral progesterone
46. A prospective randomised study of pregnancy rates following intrauterine and intracervical insemination using frozen donor sperm
47. Sterilities dc cause hormonale et sterilites inexpliquees. Traitement par le cyclofenil. Etude controlee a double insu
48. Successful fertilisation, embryo development, and pregnancy in human in vitro fertilisation (IVF) using a chemically defined culture medium containing no protein
49. Enhancement of human implantation by exogenous chorionic gonadotrophin
50. Early, late and sequential embryo transfer in in vitro fertilisation program: a preliminary report
51. Evaluating the effects of care during pregnancy and childbirth
52. Materials and methods used in synthesising evidence to evaluate the effects of care during pregnancy and childbirth
53. Immediate versus delayed progesterone supplementation in gamete intrafallopian transfer (GIFT)
54. Ovulation‐inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects
55. Empirical theory of the male with clomiphene in couples with unexplained infertility
56. Bromocriptine versus progesterone therapy for infertility related to luteal phase defects in hyperprolactinaemic patients
57. Clinical experience treating endometriosis with nafarelin
58. Interet pour la pratique de l'insemination artificielle avec sperme de donneur de l'injection d'hCG declenchant et des facteurs de prediction de l'ovulation. Etude Randomisee
59. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone results of a double‐blinded, randomised, placcbo‐controlled trial with cross‐over
60. A critical review with particular reference to the medical profession
61. Foreword
62. Immunosuppression supports implantation of zona pellucida dissected human embryos
63. Impairment of the hatching process following IVF in the human and improvement of implementation by assisting hatching using micromanipulation
64. A direct action of kallikrein on spermatozoal motility?
65. A direct action of kallikrein on spermatozoal motility?
66. The effect of doxycycline in infertile couples with male accessory gland infection: a double blind prospective study
67. Treatment of idiopathic testicular failure with high‐dose testosterone undecanoate: a double blind pilot study
68. Salpingostomy: results of two different methods of treatment
69. Induction of ovulation with cisclomiphene and a placebo
70. The medical treatment of mild endometriosis
71. Endometriosis therapy with gestrinone by oral, vaginal or parenteral administration
72. A prospective study of intrauterine insemination of processed sperm from men with oligoasthenospermia in superovulated women
73. Induction of ovulation with clomiphene citrate: a double blind study
74. Comparison of two media in a human in vitro fertilisation program: lack of significant differences in pregnancy rate
75. A randomised study of dexamethasone in ovulation induction with clomiphene citrate
76. Early or late monitoring of stimulation of ovulation for in vitro fertilisation? A methodological discussion of a randomised study
77. Steroid therapy for male infertility associated with antisperm antibodies: results of a small randomised clinical trial
78. Oil or aqueous contrast media for hysterosalpingography: a prospective, randomised, clinical study
79. A randomised, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis
80. A comparison of treatment for bilateral fimbrial occlusion
81. Effect of Tybamate on psychosomatic symptoms in a group of infertility patients: a double blind study
82. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis
83. Variable effects of danazol on endometriosis at 4 low‐dose levels
84. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomised, comparative study
85. The effect of leuprolide acetate on ovarian induction with human menopausal gonadotropins in polycystic ovary syndrome
86. Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome
87. Publication bias in clinical research
88. Clomiphene citrate in the treatment of luteal phase defects
89. Equivalency of human menopausal gonadotropin and follicle‐stimulating hormone stimulation after gonadotrophin‐releasing hormone agonist suppression
90. Clinical study on embryo after human in vitro fertilisation
91. Improvement of cervical mucus viscoelasticity and sperm penetration with sodium bicarbonate douching
92. Improved pregnancy rates and outcome with gamete intrafallopian transfer when follicular fluid is used as a sperm capacitation and gamete transfer medium
93. Gestrinone versus danazol in the treatment of endometriosis
94. Buserelin versus danazol in the treatment of endometriosis‐associated infertility
95. Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study
96. Relative efficiency of therapeutic donor insemination using a luteinising hormone monitor
97. The use of synthetic culture medium and patient serum for human in vitro fertilisation and embryo replacement
98. The value of GnRh agonists in the treatment of failed cycles in an IVF‐ET program: a comparative study
99. Evaluation of leuprolide acetate and gonadotrophins versus clomiphene citrate and gonadotrophins for in vitro fertilisation or gamete intrafallopian transfer
100. The effect of preinsemination upon fertilisation of human oocytes in vitro
101. Unexplained infertility: evaluation of treatment with clomiphene citrate and human chorionic gonadotrophin
102. General anaesthesia for intrauterine placement of human conceptuses after in vitro fertilisation
103. Treatment of infertile couples by intrauterine artificial insemination homologous (AIH) of motile sperm collected by swim‐up in human serum
104. Effects of prolactin and bromocriptine on the luteal phase in infertile women
105. Insemination of human sperm after freezing in liquid nitrogen vapours with glycerol or glycerol‐egg yolk‐citrate as protective media
106. Sperm‐freezing and donor insemination
107. A controlled trial of intrauterine insemination for cervical factor and male factor: a preliminary report
108. LHRH agonists in IVF: different methods of utilisation and comparison with previous ovulation stimulation treatments
109. Comparison between flare up and down regulation effects of luteinising hormone‐releasing hormone agonists in an in vitro fertilisation programme
110. Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitisation
111. Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease
112. Behavioural and emotional factors and treatment responses in a study of anovulatory infertile women
113. Follicular phase gonadotrophin‐releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilisation
114. Effects of kallikrein on sperm motility, capillary tube test, and pregnancy rate in an AIH programme
115. Human amniotic fluid for fertilisation and culture of human embryos: results of clinical trials in human in vitro fertilisation (IVF) programs
116. Ovarian suppression with leuprolide acctatc: comparison of luteal, follicular, and flare‐up administration in controlled ovarian hyperstimulation for oocyte retrieval
117. Effects of kallikrein on the male reproductive system and its use in the treatment of idiopathic oligozoospermia with impaired motility
118. A comparison of the effects on follicular development between clomiphene citrate, its two separate isomers and spontaneous cycles
119. The value of artificial insemination with husband's semen in infertility due to failure of postcoital sperm‐mucus penetration—controlled trial of treatment
120. Borderline hyperprolactinaemia in infertile women: evaluation of prolactin response to thyrotropin releasing hormone and double‐blind placebo‐controlled treatment with bromocriptine
121. Clomiphene treatment for women with unexplained infertility: placebo‐controlled study of hormonal responses and conception rates
122. The effect of pseudopregnancy by ovulatory suppressants on the glucose tolerance in women
123. Use of gonadotropin‐releasing hormone agonist to trigger follicular maturation for in vitro fertilisation
124. A double‐blind, placebo‐controlled study of the use of methylprednisolone in infertile men with sperm‐associated immunoglobulins
125. Stress spikes of hyperprolactinaemia and infertility
126. The use of clomiphene citrate with and without human chorionic gonadotrophin
127. Doxycycline treatment and human infertility
128. Stress, prolactin and infertility
129. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa
130. Role of nafarelin in the management of endometriosis
131. Efficacy and safety of nafarelin in the treatment of endometriosis
132. Administration of nasal nafarelin as compared with oral danazol for endometriosis: a multicentre double‐blind comparative clinical trial
133. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotrophin in in vitro fertilisation stimulated with gonadotrophin‐releasing hormone analog and menotropins
134. The two period cross‐over clinical trial
135. A double‐blind cross‐over study of the effect of doxycycline on mycoplasma infection and infertility
136. Intrauterine insemination is not useful in oligoasthenospermia
137. Ovulatory induction in clomipheneresistant anovulatory women: differential follicular response to purified urinary follicle‐stimulating hormone (FSH) versus purified urinary FSH and luteinising hormone
138. Results of artificial insemination at home by the partner with cryopreserved donor semen: a randomised study
139. Cotreatment with human growth hormone and gonadotrophins for induction of ovulation: a controlled clinical trial
140. Treatment with pulsatile luteinising hormone‐releasing hormone modulates folliculogenisis in response to ovarian stimulation with exogenous gonadotrophins in patients with polycystic ovaries
141. Combined luteinising hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries
142. A randomised double‐blind prospective trial of two doses of gestrinone in the treatment of endometriosis
143. Bromocriptine treatment of oligospermia: a double‐blind study
144. Direct intraperitoneal or intrauterine insemination and superovulation in infertility treatment: a randomised study
145. Follicular phase treatment of luteal phase defect with follicle‐stimulating hormone in infertile women
146. The primary treatment of luteal phase inadequacy: progesterone versus clomiphene citrate
147. Homologous artificial insemination for oligoasthenospermia: a randomised controlled study comparing intracervical and intrauterine techniques
148. A prospective randomised study comparing fresh semen and cryopreserved semen for artificial insemination by donor
149. Is danazol a useful treatment in unexplained primary infertility?
150. Outcome of in‐vitro fertilisation and embryo transfer after different regimens of ovarian stimulation
151. Prevention of postcervical adhesions by INTERCEED (TC7) and an absorbable adhesion barrier: a prospective randomised multicentre clinical study
152. Failure of intrauterine insemination of husband's semen
153. The treatment of male subfertility with kallikrein
154. Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women
155. Ultrasonically guided percutaneous and transvaginal follicle aspiration: a comparative study
156. The efficacy of clomiphene citrate for induction of ovulation
157. Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation
158. Computer analysis of etiology and pregnancy rate in 636 cases of primary infertility
159. Steroid treatment for infertility associated with antisperm antibodies
160. Placebo controlled study on serum concentrations of CA‐125 before and after treatment of endometriosis with danzol or high‐dose medroxyprogesterone acetate alone or after surgery
161. Steroidal drugs in endometriosis
162. Prednisolone supplementation to Chlomid and/or gonadotrophin stimulation for in vitro fertilisation—a prospective randomised trial
163. Comparison of nafarelin acetate and danazol in the treatment of endometriosis
164. Anti‐endometrial antibodies in endometriosis measured by an enzyme‐linked immunosorbent assay before and after treatment with danazol and nafarelin
165. Improved conception rate after intrauterine insemination of washed spermatozoa from men with poor quality semen
166. The effect of pneumoperitoneum gases on fertilisation, cleavage and pregnancy in human in vitro fertilisation and gamete intra‐fallopian transfer
167. Time of insemination and its effects on in vitro fertilisation, cleavage and pregnancy rates in GnRH agonist/HMG‐stimulated cycles
168. Randomised, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilisation and gamete intrafallopian transfer
169. A prospective randomised trial of human chorionic gonadotrophin or dydrogesterone support following in vitro fertilisation and embryo transfer
170. Comparison of urinary human folliclestimulating hormone and human menopausal gonadotrophin from ovarian stimulation in polycystic ovarian syndrome
171. Effect of intraperitoneal instillation of 32% Dextran 70 on post‐operative adhesion formation after tubal surgery
172. Delaying human chorionic gonadotrophin administration in human menopausal gonadotrophininduced cycles decreases successful in vitro fertilisation of human oocytes
173. Ovarian stimulation for in vitro fertilisation and embryo transfer. Human menopausal gonadotrophin versus pure human follicle stimulating hormone: a randomised prospective study
174. Support of the luteal phase in in vitro fertilisation programs: results of a controlled trial with intramuscular prolution
175. A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilisation and embryo transfer in the management of idiopathic and male infertility
176. Modifying effects of epidural analgesia or general anesthesia on the stress hormone response to laparoscopy for in vitro fertilisation
177. Comparative study of combined GIFT and IVF‐ET with GIFT alone
178. Comparative study of ultrasonically guided pericutaneous aspiration with local anaesthesia and laparoscopic aspiration of follicles in an in vitro fertilisation program
179. Ultrasonically guided oocyte collection under local anesthesia: the first choice method for in vitro fertilisation—a comparative study with laparoscopy
180. Double transfer of embryos in in vitro fertilisation, or is there a delayed receptivity of the endometrium?
181. Influence of the duration of the oestradial rise on the success rate in GnRH analogue/HMG‐stimulated IVF cycles
182. Clinical experimentation in obstetrics
183. Effectiveness of treatment for infertility
184. The alpha and beta errors in randomised trials
185. Suppression with gonadotrophin‐releasing hormone analogues prior to stimulation with gondatrophins: comparison of three protocols
186. Hormonal changes induced by shortterm administration of a gonadotrophin‐releasing hormone agonist during ovarian hyperstimulation for in vitro fertilisation and their consequences for embryo development
187. Levamisole treatment in male infertility due to spermagglutinins
188. Therapie der idiopathischen Oligozoospermie mit Bromokriptin Resultate einer prospektiv kontrollierten Studie
189. The effect of porcine relaxin vaginally applied at human embryo transfer in an in vitro fertilisation programme
190. Effects of low‐dose human chorionic gonadotrophin on corpus luteum function after embryo transfer
191. The effects of the day of initiation of ovarian stimulation in the day of luteinising hormone surge and outcome of in vitro fertilisation
192. Dummy embryo transfer: a technique that minimises the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilisation
193. Does sexual intercourse improve pregnancy rates in gamete intrafallopian transfer?
194. Intrauterine insemination dose and clomiphene citrate does not improve fecundity in couples with infertility due to male or idiopathic factors
195. Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilisation
196. Trial of 17‐hydroxyprogesterone caproate (Proloton Depot) in women with long‐standing infertility; failure of estrogen positive feedback the following cycle
197. Use of bromocriptine in unexplained infertility
198. An unexpectedly high rate of ectopic pregnancy following induction of ovulation with human pituitary and chorion gonadotrophin
199. Daily or alternate‐day FSH therapy in patients with polycystic ovarian disease resistant to clomiphene citrate treatment
200. Premature luteinisation and ovulation induction using human menopausal gonadotrophin or pure follicle stimulating hormone in patients with polycystic ovary syndrome
201. Treatment of clomiphene citrate‐resistant polycystic ovarian syndrome with pure follicle‐stimulating hormone or human menopausal gonadotrophin
202. Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband's semen in couples with male related or unexplained infertility
203. Increased viscosity in transfer medium does not improve the pregnancy rates after embryo replacement
204. Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women
205. Kallikrein and antibiotics in the treatment of infertile men with genital tract infections
206. Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men
207. Treatment of men with oligoasthenozoospermia and asthenozoospermia with kallikrein
208. Pentoxyifyllin treatment of oligoasthenospermic men
209. Kallikrein therapy of infertile men with varicocele and impaired sperm motility
210. Effect of bladder filling on embryo transfer
211. Effect of clomiphene citrate administration during the early luteal phase on the luteal function and pregnancy rate of women
212. Management of pelvic endometriosis with low‐dose danazol
213. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates
214. Luteal‐phase support in stimulated cycles in an in vitro fertilisation/embryo transfer program: progesterone versus human chorionic gonadotrophin
215. Stimulation de l'ovulation par la FSH pure en vue de fecondation in vitro. Etude de la voie d'administration
216. Ovarian stimulation by a combination of a gonadotrophin‐releasing hormone agonist and gonadotro‐phins for in vitro fertilisation
217. Improvement of semen and pregnancy rate after ligation and division of the internal spermatic vein: fact or fiction
218. Treatment of endometriosis: a study of medical management
219. The importance of laparoscopic coagulation of mild endometriosis in infertile women
220. Treatment of male infertility: is it effective?
221. Causes of implementation failure after in vitro fertilisation and embryo transfer
222. Supplementation of in vitro fertilisation culture medium with platelet activating factor
223. Analysis of clinical fertility trials: a methodologic review
224. Artificial insemination with donor cryopreserved semen: importance of the volume of semen and influence of ovulatory dysfunctions
225. The effect of cycle length on the outcome of in vitro fertilisation
226. Choice of an ovarian stimulation protocol in an in vitro fertilisation programme
227. Randomised trial of two media used for in vitro fertilisation
228. A comparative evaluation of intracervical and intrauterine routes in donor therapeutic insemination
229. Cortisone acetate versus clomiphene citrate in pre‐germinal idiopathic oligospermia
230. Ovarian response and outcome of in‐vitro fertilisation in patients treated with gonadotrophin‐releasing hormone analogues in different phases of the menstrual cycle
231. Effectiveness of treatment for infertility
232. Ovulation induction with human menopausal gonadotrophin compared to human urinary folliclestimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa‐luteal cell function
233. Clinical evaluation of clomiphene; clomiphene and human chorionic gonadotrophin; and clomiphene, human chorionic gonadotrophin and estrogens in anovulatory cycles
234. Induction of ovulation for in vitro fertilisation using buserelin and gonadotrophins
235. Controlled clinical trial of arginine for infertile men with oligozoospermia
236. Evaluation of a synthetic serum substitute to replace fetal cord serum for human oocyte fertilisation and embryo growth in vitro
237. Oral treatment of oligozoospermia with a testosterone‐undecanoate: results of a double‐blind‐placebo‐controlled trial
238. Ovulation induction in polycystic ovarian disease by pure FSH (Metrodin). A comparison between chronic low‐dose pulsatile administration and i.m. injections
239. Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline
240. Enhanced follicular recruitment in an in vitro fertilisation program: clomiphene alone versus a clomiphene/human menopausal gonadotrophin combination
241. Pure follicle stimulating hormone does not enhance follicular recruitment in clomiphene citrate/gonadotrophin combinations
242. Suboptimal laboratory conditions can affect pregnancy outcome after embryo transfer on day 1 or 2 after insemination in vitro
243. Manipulating the follicular phase in IVF cycles: a comparison of two hMG stimulation protocols
244. New techniques in fertilisation: intravaginal culture and microvolume straw
245. Intrauterine insemination and controlled ovarian hyperstimulation in cycles before GIFT
246. The duration of pituitary suppression by means of intranasal gonadotrophin hormone‐releasing hormone analogue administration does not influence the ovarian response to gonadotrophin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program
247. Artificial donor insemination: fresh versus frozen semen; the patient as her own control
248. Ovarian cyst aspiration and the outcome of in vitro fertilisation
249. Comparison of the operating microscope and loupe for microsurgical tubal anastomosis: a randomised clinical trial
250. The efficacy of post operative hydrotubation: a randomised prospective multicentre trial
251. Nafarelin versus danazol in the treatment of endometriosis
252. The comparison of early follicular and midluteal administration of long‐acting gonadotrophinreleasing hormone agonist
253. The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double‐blind study
254. Initial experiences with subcutaneous pulsatile human menopausal gonadotrophin administration: successful induction of ovulation in patients with polycystic ovarian disease
255. Treatment of infertile women with a deficient postcoital test with two antiestrogens: clomiphene and tamoxifen
256. Results of IVF in the treatment of polycystic ovary disease
257. Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in‐vitro fertilisation
258. Programmed ovulation induction and oocyte retrieval for in vitro fertilisation
259. Treatment of idiopathic oligozoospermia by kallikrein: Results of a double‐blind study
260. Split ejaculate insemination with and without the addition of kallikrein
261. Endometriosis—a reappraisal of pathogenesis and treatment
262. Hysterosalpingography with oil contrast medium enhances fertility in patients with infertility of unknown etiology
263. Comparison of urinary human folliclestimulating hormone and human menopausal gonadotrophins for ovarian stimulation in an in vitro fertilisation programme
264. Randomised trial of clomiphene citrate treatment and vitamin C for male infertility
265. Randomised trial of mesterolone versus vitamin C for male infertility
266. The effectiveness of danazol on subsequent fertility in minimal endometriosis
267. Ovulation induction in polycystic ovary syndrome with urinary follicle‐stimulating hormone or human menopausal gonadotrophin
268. Laparoscopic cauterization of endometriosis for fertility: a controlled study
269. The application of clomid in the treatment of male infertility
270. Vasovasostomy: comparison of two microsurgical techniques
271. Studies on folliculogenesis and in vitro fertilisation outcome after the administration of folliclestimulating hormone at different times during the menstrual cycle
272. Nafarelin in the treatment of pelvic pain caused by endometriosis
273. Attempts to stimulate multiple follicular growth for IVF by administration of pulsatile LHRH
274. Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme
275. The luteal phase and early pregnancy after combined GnRH‐agonist/HMG treatment for superovulation in IVF or GIFT
276. Three comparative techniques on tubo‐plasty
277. A controlled comparison of the efficacy of clomiphene citrate in male infertility
278. Bromocriptine inhibition of anaesthesiainduced hyperprolactinemia: effect on serum and follicular fluid hormones, oocyte fertilisation, and embryo cleavage rates during in vitro fertilisation
279. Die medikamentose Anregung der Ovulation in doppelten Blindversuch. Ergebnisse mit Clomiphen
280. Comparison between human serum and albumar‐20 (tm) supplement for in‐vitro fertilisation
281. The effect of different doses of human chorionic gonadotrophin in the treatment of anovulation with human gonadotrophins
282. Artificial insemination with fresh or frozen semen: a comparative study
283. The economics of inducing ovulation with human menopausal gonadotrophins versus pulsatile subcutaneous gonadotrophin‐releasing hormone
284. Clomiphene citrate and human chorionic gonadotrophin in the treatment of anovulatory infertility
285. Die Enwirkung von Grossen Intraperitonealen Dosen Glukokortikoid auf die Bildung von Postoperativen Adhasionen
286. Ultrasonic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulation
287. Ovarian stimulation in previous failures from in vitro fertilisation: distinction of two groups of poor responders
288. Stimulation with human menopausal gonadotrophin versus follicle‐stimulating hormone after pituitary suppression in polycystic ovarian syndrome
289. Assisted fertilisation in infertile women with patent fallopian tubes. A comparison of in vitro fertilisation, gamete intra‐Fallopian transfer and tubal embryo stage transfer
290. Comparison of the in vitro fertilisation rate by human sperm capacitated by multiple‐tube swim‐up and percoll gradient centrifugation
291. Intrauterine insemination of washed husband's spermatozoa: a controlled study
292. Placebo‐controlled comparison of danazol and high‐dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery
293. Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis
294. Successful treatment of asymptomatic endometriosis: does it benefit infertile women?
295. Impact of gestrinone on the course of asymptomatic endometriosis
296. Human chorionic gonadotrophin to oocyte retrieval interval in in vitro fertilisation—how critical is it?
297. Luteal support after in vitro fertilisation: a trial and rationale for selective use
298. Treatment of oligozoospermia with tamoxifen (open and controlled studies)
299. Effect of delayed insemination on in vitro fertilisation, culture and transfer of human embryos
300. The effect of progesterone supplementation around the time of oocyte recovery in patients superovulated for in vitro fertilisation
301. A comparison between laser surgery and electrosurgery for bilateral hydrosalpinx: a 2 year follow up
302. Salpingo‐ovariolysis: a comparison between laser surgery and electro‐surgery
303. Second‐look operative laparoscopy 1 year following reproductive surgery
304. A randomised, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis
305. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis
306. The effect of general anaesthesia on the success of embryo transfer following human in vitro fertilisation
307. The ‘treatment’ of unexplained infertility with danazol
308. Treatment of unexplained infertility with danazol
309. The influence of the interval between in vitro fertilisation and embryo transfer and some other variables on treatment outcome
310. The luteal phase after in‐vitro fertilisation and related procedures
311. The effects of different methods of ovarian stimulation for human in vitro fertilisation and embryo replacement
312. Luteal function in patients seeking AID
313. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia
314. Idiopathic oligospermia: control observations and response to cisclomiphene
315. A self migration method for preparation of sperm for in vitro fertilisation
316. Performance of different embryo transfer catheters in a human in vitro fertilisation program
317. Salivary oestradiol and progesterone after in vitro fertilisation and embryo transfer using different luteal support regimens
318. Mesterolone and idiopathic male infertility: a double‐blind study
319. Value of bromocriptine in unexplained primary infertility: a double‐blind controlled trial
320. The effect of therapy initiation day on clomiphene citrate therapy
321. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis
322. Assessment and hormonal treatment of the luteal phase of in vitro fertilisation cycles